Literature DB >> 18235897

Retinal detachment surgery with silicone oil injection in transconjunctival sutureless 23-gauge vitrectomy.

Rubens Camargo Siqueira1, Aline Degasperi Cote Gil, Rodrigo Jorge.   

Abstract

PURPOSE: To report a surgical technique for retinal detachment surgery using transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection.
METHODS: Thirty-one patients with retinal detachment underwent vitreoretinal surgery using a transconjunctival sutureless 23-gauge vitrectomy system. At the end of the procedure silicone oil was injected into all eyes through a microcannula. After removing the microcannula, a bipolar cautery was used in the conjunctiva over the wound to prevent silicone oil reflux.
RESULTS: In all patients retinal reattachment and injection of silicone oil through transconjunctival sutureless 23-gauge vitrectomy system was possible. Retinal re-detachment occurred in 8 patients (25.80%) who were submitted to a new vitreoretinal surgery by the technique described above, however, more extensive retinotomy was necessary in all cases, specially inferiorly. Three patients (9.67%) presented silicone oil leakage in subconjuntival compartment. Another surgical procedure was necessary to remove the subconjuntival silicone oil.
CONCLUSIONS: The retinal detachment surgery with silicone oil injection in transconjunctival sutureless 23-gauge vitrectomy is a safe and efficient technique to repair retinal detachment and it has the advantage of being minimally invasive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18235897     DOI: 10.1590/s0004-27492007000600004

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  12 in total

1.  Comparison of postoperative intraocular pressure changes between 23-gauge transconjunctival sutureless vitrectomy and conventional 20-gauge vitrectomy.

Authors:  S J Ahn; S J Woo; J Ahn; K H Park
Journal:  Eye (Lond)       Date:  2012-03-02       Impact factor: 3.775

2.  Comparison of the silicone oil removal rate between vitrectomy and manual syringe negative pressure approach.

Authors:  Zhong Lin; Rong Han Wu; Ye Hui Zhou
Journal:  Int Ophthalmol       Date:  2016-09-17       Impact factor: 2.031

3.  360° subconjunctival silicone oil after unsutured 23-gauge vitrectomy.

Authors:  I R Gorovoy; J M Stewart
Journal:  Eye (Lond)       Date:  2013-04-19       Impact factor: 3.775

4.  Risk factors for suture requirement and early hypotony in 23-gauge vitrectomy for complex vitreoretinal diseases.

Authors:  Erkut Küçük; Uğur Yılmaz; Kürşad Ramazan Zor; Defne Kalaycı; Hikmet Sarıkatipoğlu
Journal:  Int Ophthalmol       Date:  2016-09-30       Impact factor: 2.031

5.  Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion.

Authors:  Okan Toygar; Cindy W Mi; Daniel M Miller; Christopher D Riemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-19       Impact factor: 3.117

6.  Transconjunctival Sutureless 23-gauge Vitrectomy for Vitreoretinal Diseases: Outcome of 30 Consecutive Cases.

Authors:  Ashraf M El-Batarny
Journal:  Middle East Afr J Ophthalmol       Date:  2008-07

7.  Passive Removal of Silicone Oil with Temporal Head Position through Two 23-Gauge Cannulas.

Authors:  Zhong Lin; Zhi Sheng Ke; Qian Zheng; Zhen Quan Zhao; Zong Ming Song
Journal:  J Ophthalmol       Date:  2016-06-22       Impact factor: 1.909

8.  Dellen formation as a complication of subconjunctival silicone oil following microincision vitrectomy.

Authors:  Mohamed M Mahgoub; Maged M Roshdy; Sherine S Wahba
Journal:  Clin Ophthalmol       Date:  2017-12-15

9.  Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection.

Authors:  Tansu Erakgun; Sait Egrilmez
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

Review 10.  Sutureless vitrectomy.

Authors:  Sunil K Warrier; Rajeev Jain; Jagjit Singh Gilhotra; Henry S Newland
Journal:  Indian J Ophthalmol       Date:  2008 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.